Edoxudine

Edoxudine
Clinical data
ATC code	D06BB09(WHO);
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;
CAS Number	15176-29-1;
PubChemCID	66377;
ChemSpider	59752;
UNII	15ZQM81Y3R;
ChEMBL	ChEMBL318153;
CompTox Dashboard(EPA)	DTXSID4045890;
ECHA InfoCard	100.035.645
Chemical and physical data
Formula	C11H16N2O5
Molar mass	256.258g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C/1NC(=O)N(\C=C\1CC)[C@@H]2O[C@@H]([C@@H](O)C2)CO;
	InChI InChI=1S/C11H16N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h4,7-9,14-15H,2-3,5H2,1H3,(H,12,16,17)/t7-,8+,9+/m0/s1; Key:XACKNLSZYYIACO-DJLDLDEBSA-N;
	(what is this?)(verify)

Edoxudine(oredoxudin) is anantiviral drug.It is an analog ofthymidine,anucleoside.

It has shown effectiveness againstherpes simplex virus.^[1]

References[edit]

^Hamuy R, Berman B (December 1998). "Topical antiviral agents for herpes simplex virus infections".Drugs of Today.34(12): 1013–1025.doi:10.1358/dot.1998.34.12.487486.PMID 14743269.

Thisantiinfective drugarticle is astub.You can help Wikipedia byexpanding it.

Thisdermatologic drugarticle is astub.You can help Wikipedia byexpanding it.